Thousands of Americans struggle with opioid use disorder (OUD), and while there are three widely available drug treatments for OUD, only about one in five receive OUD medications to combat it. The opioid epidemic has blazed on for decades, and public health officials continue to…
With more than two million Americans battling opioid use disorder (OUD), the U.S. Food and Drug Administration (FDA) recently approved the first DNA test to assess whether or not a person is at an elevated risk of becoming addicted to the drugs. The AvertD test,…
In March 2024, the leadership for the Suboxone tooth decay multidistrict litigation (MDL) was chosen. Of the 20 attorneys appointed, four hold the position of co-lead counsel, five will serve on the Plaintiff’s Executive Committee, and the remainder were named to the Plaintiffs’ Steering Committee.…
For people struggling with opioid use disorder, Suboxone can be a godsend. The drug contains buprenorphine and naloxone, which reduce withdrawal symptoms and prevent drug cravings. Suboxone use is associated with a decreased risk of fatal overdoses, and the global suboxone market is expected to…
The opioid crisis stretches back to the 1990s. It was triggered in large part by OxyContin, manufactured by Purdue Pharma and approved by the U.S. Food and Drug Administration (FDA). It is continuing well into its third decade, with heroin and fentanyl fanning the flames.…
The manufacturers of a popular drug effective at treating opioid use disorder (OUD) are facing lawsuits from patients who say it gave them severe, often permanent dental problems. Suboxone, a brand-name prescription drug administered via a film placed under the tongue, contains buprenorphine and naloxone.…
The opioid crisis has devastated families across the world and caused preventable deaths. Drug overdoses have taken more than a million lives since 1999, according to data from the Centers for Disease Control and Prevention. Purdue Pharma, a pharmaceutical company worth billions of dollars, faces…